In the latest trading session,, 1.08 million GoodRx Holdings Inc (NASDAQ:GDRX) shares changed hands as the company’s beta touched 1.17. With the company’s most recent per share price at $4.43 changing hands around $0.32 or 7.78% at last look, the market valuation stands at $1.58B. GDRX’s current price is a discount, trading about -109.03% off its 52-week high of $9.26. The share price had its 52-week low at $3.67, which suggests the last value was 17.16% up since then. When we look at GoodRx Holdings Inc’s average trading volume, we note the 10-day average is 1.1 million shares, with the 3-month average coming to 1.46 million.
Analysts gave the GoodRx Holdings Inc (GDRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.06. If we narrow down to specifics, the data shows that 0 out of 16 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 7 recommended GDRX as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight.
GoodRx Holdings Inc (NASDAQ:GDRX) trade information
Instantly GDRX is in green as seen in intraday trades today. With action 12.43%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -4.73%, with the 5-day performance at 12.43% in the green. However, in the 30-day time frame, GoodRx Holdings Inc (NASDAQ:GDRX) is 2.54% up. Looking at the short shares, we see there were 4.24 million shares sold at short interest cover period of 2.67 days.
The consensus price target for the stock as assigned by Wall Street analysts is 10, meaning bulls need an upside of 55.7% from its recent market value. According to analyst projections, GDRX’s forecast low is 3 with 45 as the target high. To hit the forecast high, the stock’s price needs a -915.8% plunge from its current level, while the stock would need to tank 32.28% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -17.73%. The 2025 estimates are for GoodRx Holdings Inc earnings to increase by 14.52%, but the outlook for the next 5-year period is at 14.67% per year.
GDRX Dividends
GoodRx Holdings Inc is expected to release its next quarterly earnings report on 2025-May-06.
GoodRx Holdings Inc (NASDAQ:GDRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 12.49% of GoodRx Holdings Inc shares while 62.93% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 71.91%. There are 62.93% institutions holding the GoodRx Holdings Inc stock share, with FRANCISCO PARTNERS MANAGEMENT, LP the top institutional holder. As of 2024-06-30, the company held 18.6252% of the shares, roughly 70.08 million GDRX shares worth $546.61 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 2.1614% or 8.13 million shares worth $63.43 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund . With 2.68 shares estimated at $11.95 million under it, the former controlled 2.68% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund held about 2.20% of the shares, roughly 2.21 shares worth around $9.83 million.
